ArticleOpen forum infectious diseases2017
Infliximab Biosimilars: A Promising but Unusual Treatment for Mycobacterial Immune Reconstitution Inflammatory Syndrome in Human Immunodeficiency Virus-Infected Patients.
Jesús Troya et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.